Neuroscience blog

View Details

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.  
View Details

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.

RMEI DECISION SUPPORT AIDS

View Details

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.
View Details

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

LATEST NEUROSCIENCE ARTICLES

RSS feed: Latest Neuroscience Articles Latest Neuroscience Articles
  • Functional Fixed Dystonia of the Foot November 14, 2026
    A previously healthy 23-year-old woman presented with an 11-month history of foot pain and difficulty walking. Neurologic examination showed the left foot fixed in plantar flexion and inversion (shown in a video).
    Jorik Nonnekes, Annemieke de Greef-Rotteveel
  • Interferon-γ Underlying Thymoma-Associated Immune Dysregulation November 12, 2026
    In an observational study, thymoma-associated immune dysregulation was characterized by interferon-γ pathway activation. Four patients with severe disease treated with Janus kinase 1/2 inhibitors had clinical and biomarker responses.
    Iivo Hetemäki, Chen Wang, Rachel Wu, Joseph Pechacek, Taura Webb, Deanna Riley, Lucas dos Santos Dias, Heather Moorman, Princess Barber, Lindsey B. Rosen, Annalie Harris, Sebastian Ochoa, Karthik Darma, Maria Semenova, Laercio Lopez Da Silva, Kai Kisand, Tovah E. Markowitz, Peter D. Burbelo, Monika Fischer, Mark Raffeld, Tyler Hulett, Jennifer Stoddard, Sergio D. Rosenzweig, Christopher G. Kanakry, Kathy L. McGraw, Joseph Rocco, Luigi D. Notarangelo, Christa S. Zerbe, Ivan Fuss, Anjali Rai, Theo Heller, Patrick J. Loehrer, Eliisa Kekäläinen, Alexandra F. Freeman, Arun Rajan, Timi Martelius, Katherine R. Calvo, Steven M. Holland, Roderick Marion, Stefania Pittaluga, Michail S. Lionakis
  • Intensive Blood-Pressure Control in Patients with Previous Ischemic Stroke November 7, 2026
    In patients with previous ischemic stroke or transient ischemic attack, a systolic blood-pressure target below 120 mm Hg was associated with fewer major cardiovascular events than a target below 140 mm Hg.
    Gisele Sampaio Silva, M. Julia Machline-Carrion, Karla Santo, João Brainer Clares de Andrade, Eduardo Martins, Patrícia Oliveira Guimarães, Frederico Monfardini, Josué Nieri, Silvia R.L. Assis, Sheila Cristina Ouriques Martins, Octávio Marques Pontes Neto, Audes D.M. Feitosa, Carla Heloisa Cabral Moro, Sandra C. Fuchs, Rubens Gagliardi, Odilson Silvestre, Ricardo Pereira Silva, Murillo Antunes, Eva Carolina Rocha, Cesar Minelli, Lilia Nigro Maia, Luiz A. Bortolotto, Marcio Gonçalves Sousa, Luciano F. Drager, Rodrigo Bazan, José F. Vilela-Martin, Jamary Oliveira-Filho, Viviane Flumignan Zétola, Wagner Avelar, Leonardo Augusto Carbonera, Gabriel Pereira Braga, Adriana Bastos Conforto, Caio A.M. Tavares, Fabrício Oliveira Lima, Gladys L. Martins, Letícia Costa Rebello, Anthony Rodgers, Paul K. Whelton, Flavio D. Fuchs, Otavio Berwanger, the OPTIMAL-STROKE Trial Investigators*

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Previously Published CE Activities